Low-dose aspirin does not reduce risk of CV events in patients with diabetes
Monday, November 10, 2008 - 09:35
in Health & Medicine
Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA...